Slate Path Capital LP Nex Immune, Inc. Transaction History

Slate Path Capital LP

  • $5.09 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.3 - $0.6 $277,500 - $555,000
925,000 New
925,000 $351,000
Q1 2021

May 17, 2021
BUY
$17.95 - $25.91 $16.6 Million - $24 Million
925,000 New
925,000 $17.6 Million

About NexImmune, Inc.

NEXI Quotes by TradingView
  • Ticker NEXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,155,600
  • Market Cap $6.04M
  • Description
  • NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...
More about NEXI
Track This Portfolio

Track Slate Path Capital LP Portfolio

Follow Slate Path Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Slate Path Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Slate Path Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email